Media headlines about CAS Medical Systems (NASDAQ:CASM) have been trending somewhat positive this week, according to Accern Sentiment Analysis. The research firm scores the sentiment of media coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. CAS Medical Systems earned a daily sentiment score of 0.19 on Accern’s scale. Accern also assigned news coverage about the medical technology company an impact score of 46.7794561692322 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.
Shares of CAS Medical Systems (CASM) traded down 3.03% on Friday, reaching $0.96. 12,450 shares of the company’s stock were exchanged. CAS Medical Systems has a one year low of $0.80 and a one year high of $1.94. The stock’s market cap is $26.24 million. The company’s 50 day moving average is $1.12 and its 200-day moving average is $1.24.
CAS Medical Systems (NASDAQ:CASM) last posted its quarterly earnings results on Tuesday, August 8th. The medical technology company reported ($0.09) EPS for the quarter, missing the consensus estimate of ($0.07) by $0.02. The firm had revenue of $4.57 million during the quarter, compared to analyst estimates of $5.41 million. On average, analysts anticipate that CAS Medical Systems will post ($0.27) EPS for the current year.
WARNING: This article was originally reported by BNB Daily and is owned by of BNB Daily. If you are accessing this article on another publication, it was illegally copied and republished in violation of US & international copyright & trademark law. The original version of this article can be viewed at https://www.baseball-news-blog.com/2017/08/19/cas-medical-systems-casm-earns-media-sentiment-rating-of-0-19-updated.html.
About CAS Medical Systems
CAS Medical Systems, Inc is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products for patient care. The Company designs, manufactures and distributes the FORE-SIGHT and FORE-SIGHT ELITE brand tissue oximeters and sensors. It operates through Tissue Oximetry Monitoring, which includes sales of its FORE-SIGHT tissue oximeter monitors, sensors and accessories.
Receive News & Ratings for CAS Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CAS Medical Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.